skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Benzo(a)pyrene and 7,12-dimethylbenz(a)anthrecene differentially affect bone marrow cells of the lymphoid and myeloid lineages

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [2];  [1];  [3]
  1. Molecular and Environmental Toxicology, University of Wisconsin, 1300 University Avenue, Madison, WI 53706 (United States)
  2. Department of Pathological Sciences, University of Wisconsin, 2015 Linden Drive, Madison, WI 53706 (United States)
  3. Molecular and Environmental Toxicology, University of Wisconsin, 1300 University Avenue, Madison, WI 53706 (United States) and Department of Pharmacology, University of Wisconsin, 1300 University Avenue, Madison, WI 53706 (United States)

Polycyclic aromatic hydrocarbons (PAHs) are common environmental contaminants that are carcinogenic and immunosuppressive. Benzo(a)pyrene (BP) and 7,12-dimethylbenz(a)anthracene (DMBA) are two prototypic PAHs known to impair the cell-mediated and humoral immune responses. We have previously shown that, in C57BL/6J mice, total bone marrow (BM) cellularity decreased two-fold following intraperitoneal DMBA treatment but not BP treatment. Here, we have used flow cytometry to demonstrate that BP and DMBA differentially alter the lymphoid and myeloid lineages. Following DMBA treatment, the pro/pre B-lymphocytes (B220{sup lo}/IgM{sup -}) and the immature B-lymphocytes (B220{sup lo}/IgM{sup +}) significantly decreased, while the mature B-lymphocytes (B220{sup hi}/IgM{sup +}) remained unaffected. In contrast, BP treatment decreased the pro/pre B-lymphocytes, and did not affect the immature B-lymphocytes or mature B-lymphocytes. The Gr-1{sup +} cells of the myeloid lineage were depleted 50% following DMBA treatment and only minimally depleted following BP treatment. Interestingly, the monocytes (7/4{sup +}1A8{sup lo}) and neutrophils (7/4{sup +}1A8{sup hi}) within this Gr-1{sup +} population were differentially affected by these PAHs. Monocytes and neutrophils were depleted following DMBA treatment whereas neutrophils decreased and monocytes increased following BP treatment. Although TNF{alpha} and CYP1B1 are implicated as essential mediators of hypocellularity, the similar induction of TNF{alpha} mRNA and CYP1B1 mRNA in the BM by BP and DMBA suggests that they are not limiting factors in mediating the different effects of these PAHs. Given that similar amounts of BP and DMBA reach the BM when administered intraperitoneally, their differential effects on the lymphoid and myeloid lineages probably stem from differences in reactive metabolites such as PAH quinones and PAH-dihydrodiol-epoxides.

OSTI ID:
20850332
Journal Information:
Toxicology and Applied Pharmacology, Vol. 213, Issue 2; Other Information: DOI: 10.1016/j.taap.2005.09.018; PII: S0041-008X(05)00563-6; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English